SecBot SecBot
SC 13D/A ·Filed Oct 15, 2026

TCRT

Alaunos Therapeutics, Inc.
NEUTRAL
Impact 6/10
Horizonweeks Processed11d 14h ago SEC0001193805-26-001370
Activist stake amendment (position change)
Actionable Insight • Neutral

The activist is fully aligned with the merger path — the preferred conversion, voting agreement, and conditional board resignation signal Postma is exiting via the merger rather than escalating demands. Monitor the stockholder vote on the conversion proposal — if approved, Postma's shares are repurchased and he exits the board, effectively ending the activist campaign. The 9.99% blocker caps his stake prevents further accumulation.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
TCRT ▼ -13.31% at T+5d
NEUTRAL call -13.31% · α vs SPY -12.88% · entry $2.63 → $2.28
Next anchor: T+20d in 16d
Entry = T+0 close
Oct 15, 2026
via day close
T+1d
+19.01%
call +19.01% · α +18.59%
$3.13
settled 11d ago
T+5d
-13.31%
call -13.31% · α -12.88%
$2.28
settled 5d ago
T+20d
Pending
in 16d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Robert W. Postma and WaterMill Asset Management Corp. filed an amended Schedule 13D disclosing a 9.99% beneficial ownership stake in Alaunos Therapeutics (TCRT) as of October 13, 2026, following the company's merger agreement with Velaris Therapeutics. The filing details a Share Repurchase and Voting Agreement under which Postma and other preferred holders agreed to convert their Series A-1 and A-2 preferred shares into common stock, vote in favor of the merger proposals, and have their shares repurchased for approximately $1.6 million. Postma also submitted a conditional resignation from the board, effective upon stockholder approval of the conversion proposal.

Key Financial Metrics

Stake
9.99%
Investor
Robert W. Postma / WaterMill Asset Management Corp.

Key Facts

  • Robert W. Postma and WaterMill Asset Management Corp. report beneficial ownership of 9.99% of Alaunos common stock as of October 13, 2026.
  • The stake includes 80,438 common shares held directly by Postma, 62,416 held by WaterMill Asset Management, 24 shares in Postma's spouse's IRA, plus shares issuable upon conversion of Series A-1 and A-2 preferred stock and options exercisable within 60 days.
  • Postma entered into a Share Repurchase and Voting Agreement with Alaunos and Velaris Therapeutics, agreeing to convert preferred shares to common, vote for the merger, and have shares repurchased for ~$1.6 million.
  • Postma delivered a conditional resignation from the board, effective only upon stockholder approval of the conversion proposal.
  • Postma and certain officers/directors entered into 180-day lock-up agreements on sale or transfer of shares held at closing.

Financial Impact

Approximately $1.6 million aggregate cash repurchase of preferred stock liquidation value plus accrued dividends for Postma and other preferred holders.

dilutionmerger considerationboard composition

Risk Factors

  • If the merger fails or stockholder approval is not obtained, Postma's conditional resignation does not take effect and he remains on the board with preferred shares still outstanding.
  • The 9.99% beneficial ownership blocker limits Postma's ability to increase stake, capping influence.
  • The $1.6 million repurchase is small relative to the $350 million PIPE and $200 million Velaris valuation, suggesting Postma's exit is a minor side event to the larger merger.

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13D/A Filing (Primary)0001193805-26-001370
Document: 0001193805-26-001370-index.html0001193805-26-001370
Document: 0001193805-26-001370.txt0001193805-26-001370
13 reports for TCRT
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 7 best @ T+60▲ +26.36%Apr 15, 2026
Filters
Rows
Reports for TCRT — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
8-K
BULLISH ★ 5/10
$2.39awaiting T+20—$1.98 (−17.07%)
Oct 21, 2026
5d ago
8-K
BULLISH ★ 7/10
$3.04awaiting T+20—$1.98 (−34.87%)
Oct 15, 2026
11d ago
SC 13D/A
NEUTRAL ★ 6/10
$2.63awaiting T+20—$1.98 (−24.71%)
Oct 15, 2026
11d ago
SC 13D
NEUTRAL ★ 5/10
$2.63awaiting T+20—$1.98 (−24.71%)
Oct 13, 2026
14d ago
Press Release
BULLISH ★ 8/10
$3.03awaiting T+20—$1.98 (−34.65%)
Oct 13, 2026
14d ago
8-K
BULLISH ★ 8/10
$3.03awaiting T+20—$1.98 (−34.65%)
Oct 9, 2026
17d ago
8-K
BEARISH ★ 7/10
$1.05awaiting T+20—$1.98 (−88.57%)
Sep 18, 2026
5w ago
Press Release
BEARISH ★ 5/10
$1.20 $2.63▼ −119.17%▼ −118.96%$1.98 (−65.00%)
Sep 16, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$1.60 $2.18▲ +36.25%▲ +34.79%$1.98 (+23.75%)
Jun 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$2.37 $1.94▼ −18.14%▼ −17.86%$1.98 (−16.46%)
Showing 10 of 13

US Market Status

Market Open — Closes in 5h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 15, 2026